Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-09-12Clinical Trial Update: Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS) [Phase 4]
Phase 4 trial update for the Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS) has completed; sponsor is The George Institute a…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Effect of Alirocumab(Proprotein Convertase Subtilisin/Kexin type9 Inhibitor) and Rosuvastatin or Rosuvastatin Alone on Lipid Core Plaques in Coronary Artery Disease Evaluated by Near-infrared Spectroscopy Intravascular Ultrasound [Phase 4]
A Phase 4 trial evaluating the effect of alirocumab (PCSK9 inhibitor) with rosuvastatin versus rosuvastatin alone on lipid core plaques in c…
-
FDA approval · 2018-08-30FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approves Upsher-Smith's generic diltiazem hydrochloride through an original ANDA (ANDA205231) for use as a calcium channel blocker.
-
FDA approval · 2018-08-29FDA Approved: ISOSORBIDE MONONITRATE — Original Application (Chartwell RX, LLC)
FDA approved an original ANDA for isosorbide mononitrate by Chartwell RX, LLC, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2018-08-16Clinical Trial Update: DaZhu Rhodiola Rosea Capsule for Coronary Artery Disease With Angina Pectoris [Phase 4]
Phase 4 clinical trial update for DaZhu Rhodiola Rosea Capsule in coronary artery disease with angina pectoris is reported, status unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-07-30FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Nitroglycerin submitted by Prasco Laboratories, signaling an approval-related action affecting t…
-
FDA approval · 2018-07-23FDA Approved: NADOLOL — Original Application (UNICHEM PHARMACEUTICALS (USA), INC.)
FDA approved Nadolol as an original application from Unichem Pharmaceuticals (USA), Inc., establishing a generic nadolol product.
-
FDA approval · 2018-07-13FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal's VERAPAMIL HYDROCHLORIDE as an original ANDA generic product.
-
FDA approval · 2018-06-29FDA Approved: NIFEDIPINE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for Nifedipine from Zydus Lifesciences Limited, a generic calcium channel blocker used for hypertensio…
-
FDA approval · 2018-06-18FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approves Somerset Therapeutics' Verapamil hydrochloride as an original application, granting a generic version of the drug.
-
CLINICAL_TRIALS research · 2018-06-06Clinical Trial Update: GLP-1 Loading During Elective Percutaneous Coronary Intervention [Phase 2]
An update on a Phase 2 clinical trial investigating GLP-1 loading during elective percutaneous coronary intervention; current status is unkn…
-
FDA approval · 2018-05-21FDA Approved: NIFEDIPINE — Supplemental Application (Leading Pharma, LLC)
The FDA approved a supplemental application for nifedipine submitted by Leading Pharma, LLC.
-
CLINICAL_TRIALS trial_result · 2018-05-04Clinical Trial Update: Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina [NA]
Completed clinical trial evaluating extracorporeal shockwave myocardial revascularization for refractory angina.
-
FDA approval · 2018-04-26FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Epic Pharma, LLC)
The FDA approved a supplemental application for the generic drug amlodipine besylate submitted by Epic Pharma, LLC. This represents authoriz…
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (ACI Healthcare USA, Inc.)
FDA approved a supplemental application for amlodipine besylate (generic) filed by ACI Healthcare USA, Inc., supporting continued marketing …
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Exelan Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate from Exelan Pharmaceuticals, Inc., approving a generic product.
-
FDA approval · 2018-04-23FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (POLYGEN PHARMACEUTICALS INC.)
FDA approved a supplemental application for amlodipine besylate from PolyGen Pharmaceuticals, approving a generic version.
-
FDA approval · 2018-04-20FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved Cipla USA Inc.'s supplemental application for amlodipine besylate under ANDA077073.
-
CLINICAL_TRIALS trial_result · 2018-04-12Clinical Trial Update: Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site
The Johns Hopkins University–sponsored registry evaluating non-primary angioplasty at hospitals without on-site surgical capability has comp…
-
CLINICAL_TRIALS trial_result · 2018-04-06Clinical Trial Update: Cardiac SPECT With Rotating Slant Hole Collimator
A completed clinical trial update reports the completion of a Cardiac SPECT study using a rotating slant hole collimator conducted by Johns …
-
FDA approval · 2018-04-02FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate filed by PD-Rx Pharmaceuticals, Inc. The action concerns a supplemental appr…
-
FDA approval · 2018-04-02FDA Approved: AMLODIPINE BESYLATE 2.5 MG — Supplemental Application (Oxford Pharmaceuticals, LLC)
FDA approves a supplemental application to add a 2.5 mg strength of amlodipine besylate (generic) manufactured by Oxford Pharmaceuticals, ex…
-
FDA approval · 2018-03-23FDA Approved: METOPROLOL SUCCINATE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for METOPROLOL SUCCINATE (generic) from Zydus Pharmaceuticals (USA) Inc., authorizing its marketing as…
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the Supplemental Application for Aurobindo Pharma Limited to market amlodipine besylate as a generic formulation.
-
FDA approval · 2018-03-14FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for amlodipine besylate filed by Zydus Pharmaceuticals USA Inc. The action confirms approval of …